Histone Deacetylase Inhibitors: all 1,242 studies that test it
Page 10 of 13. Open to participants first (144), then studies with results posted, then the rest; newest registration first within each.
- Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell LymphomaWithdrawnNCT01386398Phase 3
- Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck CancerCompletedNCT01384799Phase 1
- High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent GliomaTerminatedNCT01378481Phase 1
- Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral TherapyStatus unknownNCT01365065Phase 2
- A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural MesotheliomaWithdrawnNCT01353482Phase 1/2
- Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)CompletedNCT01344707Phase 1
- Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven TumorsStatus unknownNCT01341834Phase 1
- Study of Pazopanib and Vorinostat in Patients With Advanced MalignanciesCompletedNCT01339871Phase 1
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsCompletedNCT01336842Phase 1
- Valproic Acid With Chemoradiotherapy for Pancreatic CancerStatus unknownNCT01333631Phase 2
- Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple MyelomaCompletedNCT01323751Phase 1/2
- A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological MalignanciesCompletedNCT01317927Phase 1
- MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLCCompletedNCT01310244Phase 1/2
- A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)Active, not recruitingNCT01305499Phase 2
- Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT01301807Phase 1
- LBH589 (Panobinostat) for the Treatment of MyelofibrosisStatus unknownNCT01298934Phase 1/2
- A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple MyelomaActive, not recruitingNCT01297764Phase 1/2
- Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)Status unknownNCT01295593Phase 1/2
- 4SC-201 (Resminostat) in Advanced Colorectal CarcinomaCompletedNCT01277406Phase 1/2
- Study of Carfilzomib and Vorinostat for Relapsed or Refractory LymphomaCompletedNCT01276717Phase 1
- Sirolimus or Vorinostat and Hydroxychloroquine in Advanced CancerCompletedNCT01266057Phase 1
- Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)CompletedNCT01242774Phase 1
- Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based ChemotherapyTerminatedNCT01238965Phase 1
- Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic ProfileStatus unknownNCT01226407Phase 1
- LBH Phase II in Small Cell Lung Cancer (SCLC)CompletedNCT01222936Phase 2
- Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent NeuroblastomaCompletedNCT01208454Phase 1
- Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
- Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung CancerStatus unknownNCT01203735Phase 1/2
- A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung CancerTerminatedNCT01188707Phase 1/2
- A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and LeukemiaCompletedNCT01184274Phase 1
- Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent ChordomaStatus unknownNCT01175109Phase 1
- Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerTerminatedNCT01174199Phase 1
- A Study of Divalproex Sodium in Children With ASD and Epileptiform EEGWithdrawnNCT01170325Phase 2
- Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerWithdrawnNCT01160731Phase 1
- LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid TumorsStatus unknownNCT01159418Phase 1
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaTerminatedNCT01159301Phase 1
- A Safety and Tolerability Study of PCI-24781 in Subjects With CancerCompletedNCT01149668Phase 1
- Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment FailureCompletedNCT01136499Phase 2
- A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and LymphomasCompletedNCT01132911Phase 1
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic LeukemiaCompletedNCT01132573Phase 1
- Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01132196Phase 1
- Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Reddy's Under Fasting Condition (Apple Sauce)CompletedNCT01132183Phase 1
- Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting ConditionsCompletedNCT01132170Phase 1
- Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT01130506Phase 1
- Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaTerminatedNCT01116154Phase 1
- Seizures Post Intracerebral HemorrhageCompletedNCT01115959Phase 4
- A Panobinostat PresurgeryWithdrawnNCT01115036Phase 2
- A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic SarcomasCompletedNCT01112384Phase 2
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasCompletedNCT01106872Phase 1
- Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3WithdrawnNCT01096095Phase 2
- A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective DisorderCompletedNCT01094249Phase 1
- Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerTerminatedNCT01090830Phase 1/2
- Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast CancerCompletedNCT01084057Phase 1
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic SyndromeCompletedNCT01075425Phase 1
- SB939 in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT01075308Phase 2
- Safety Study of Depakote Versus Lithium in African Americans With Bipolar DisorderWithdrawnNCT01075126Phase 4
- Sorafenib and Vorinostat in Treating Patients With Advanced Liver CancerCompletedNCT01075113Phase 1
- Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal SubjectsCompletedNCT01073059Phase 1
- Panobinostat (LBH589) in Patients With Metastatic MelanomaCompletedNCT01065467Phase 1
- Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell CarcinomaCompletedNCT01064921Phase 1
- A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy MenCompletedNCT01060228Phase 1
- Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059552Phase 1
- Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed ConditionCompletedNCT01056627Phase 1
- Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting ConditionsCompletedNCT01055938Phase 1
- Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid TumorsCompletedNCT01055795Phase 1
- A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01038388Phase 1
- Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's LymphomaCompletedNCT01037478Phase 2
- Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's LymphomaTerminatedNCT01032148Phase 1
- A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host DiseaseWithdrawnNCT01028313Phase 2
- Hydroxychloroquine + Vorinostat in Advanced Solid TumorsCompletedNCT01023737Phase 1
- N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed NeuroblastomaCompletedNCT01019850Phase 1
- Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaStatus unknownNCT01016990Phase 2
- Adjuvant Valproate for High Grade SarcomasTerminatedNCT01010958Phase 1
- Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic FunctionCompletedNCT01007968Phase 1
- Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a PilotTerminatedNCT01007695Phase 1
- Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung CancersCompletedNCT01005797Phase 1
- Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal FunctionCompletedNCT00997399Phase 1
- Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose CytarabineCompletedNCT00995332Phase 1/2
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
- ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast CancerWithdrawnNCT00993642Early Phase 1
- Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative DisordersTerminatedNCT00992732Phase 2
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic CancerCompletedNCT00983268Phase 1
- Divalproex Sodium 500 mg Extended Release Tablets Under Fasting ConditionsCompletedNCT00974441Phase 1
- Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting ConditionsCompletedNCT00974012Phase 1
- Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)TerminatedNCT00972842Phase 1/2
- Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT00963274Phase 1
- Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCompletedNCT00962507Phase 1
- Carboplatin and Etoposide Plus LBH589 for Small Cell Lung CancerTerminatedNCT00958022Phase 1
- Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung CancerCompletedNCT00946673Phase 1
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersCompletedNCT00926640Phase 1
- Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)CompletedNCT00918489Phase 2
- Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid MalignanciesTerminatedNCT00917826Phase 2
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting ConditionsCompletedNCT00913874Phase 1
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed ConditionsCompletedNCT00913848Phase 1
- Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00907179Phase 1
- Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell LymphomaCompletedNCT00901147Phase 2
- Panobinostat/Velcade in Multiple MyelomaTerminatedNCT00891033Phase 1
- Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid TumorsCompletedNCT00878904Phase 1
- Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by SurgeryTerminatedNCT00873002Phase 1